Directory
Portfolio companies.
34,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
164
currently held
Exits tracked
44
hand-checked
Sectors covered
1
across the portfolio
Countries covered
1
from every market
Latest activity
Capital Event · capital-cancellation-shares · Capital structure change
capitalCapital Event · capital-cancellation-shares · Capital structure change
capitalCapital Event · capital-cancellation-shares · Capital structure change
capitalCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway
adminBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board
admin203 companies matching · Page 4 of 5
Deka Biosciences
Leaps by Bayer
Sector
Biotech
InvestorLeaps by Bayer
Entry
2021
Hold
5yr
Edgewise Therapeutics
Novo Holdings Venture Investments
Sector
Biotech
InvestorNovo Holdings
Entry
2019
Hold
7yr
Enveda Biosciences
Kinnevik
Sector
Biotech
InvestorKinnevik
Entry
2023
Hold
3yr
Expedition Therapeutics
Novo Holdings Venture Investments
Sector
Biotech
InvestorNovo Holdings
Entry
2025
Hold
1yr
Galilei Biosciences
Apollo Health Ventures Fund II
Sector
Biotech
InvestorApollo Health Ventures
Entry
2021
Hold
5yr
Geneos Therapeutics
Flerie Invest
Sector
Biotech
InvestorFlerie
Entry
2022
Hold
4yr
GenEP
Angelini Ventures
Sector
Biotech
InvestorAngelini Ventures
Entry
2021
Hold
5yr
Geno
Novo Holdings Bioindustrial Investments
Sector
Biotech
InvestorNovo Holdings
Entry
2021
Hold
5yr
iECURE
Novo Holdings Venture Investments
Sector
Biotech
InvestorNovo Holdings
Entry
2022
Hold
4yr
Immunitas Therapeutics
Leaps by Bayer
Sector
Biotech
InvestorLeaps by Bayer
Entry
2021
Hold
5yr
Immunorx Pharma, Inc.
TVM Life Science Innovation
Sector
Biotech
InvestorTVM Capital Life Science
Entry
2021
Hold
5yr
InCarda Therapeutics Inc.
HealthCap VII
Sector
Biotech
InvestorHealthCap
Entry
2018
Hold
8yr
Invoke Bio
HCVC Hardware Club Fund II
Sector
Biotech
InvestorElephants & Ventures / Hardware Club
Entry
–
Izote Biosciences
Nucleus Capital II
Sector
Biotech
InvestorNucleus Capital
Entry
2024
Hold
2yr
Karuna Therapeutics
General Atlantic
Sector
Biotech
InvestorGeneral Atlantic
Entry
–
LAmAb Biologics, Inc.
TVM Life Science Innovation
Sector
Biotech
InvestorTVM Capital Life Science
Entry
2023
Hold
3yr
Larq
Health for Life Capital
Sector
Biotech
InvestorSeventure Partners
Entry
2020
Hold
6yr
Leal Therapeutics
Dementia Discovery Fund 2
Sector
Biotech
InvestorSV Health Managers
Entry
2025
Hold
1yr
Libra Therapeutics
Boehringer Ingelheim Venture Fund
Sector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
2020
Hold
6yr
Macro Biologics
Oscar & Paul Venture Capital Fund I
Sector
Biotech
InvestorOscar & Paul (Beiersdorf Venture Capital)
Entry
2024
Hold
2yr
Mage Biologics, Inc.
TVM Life Science Innovation
Sector
Biotech
InvestorTVM Capital Life Science
Entry
2023
Hold
3yr
Mahzi Therapeutics
HealthCap VII
Sector
Biotech
InvestorHealthCap
Entry
2020
Hold
6yr
MapLight Therapeutics
Novo Holdings Growth Investments
Sector
Biotech
InvestorNovo Holdings
Entry
2023
Hold
3yr
Montara Therapeutics
Dementia Discovery Fund
Sector
Biotech
InvestorSV Health Managers
Entry
2024
Hold
2yr
Novos
Unilever Ventures (Evergreen)
Sector
Biotech
InvestorUnilever Ventures
Entry
2026
Hold
0yr
Obsidian Therapeutics
Novo Holdings Venture Investments
Sector
Biotech
InvestorNovo Holdings
Entry
2024
Hold
2yr
OnCusp Therapeutics
Novo Holdings Venture Investments
Sector
Biotech
InvestorNovo Holdings
Entry
2024
Hold
2yr
One Bio ex BCD...
Health for Life Capital
Sector
Biotech
InvestorSeventure Partners
Entry
2022
Hold
4yr
PDS Biotechnology
EMV Capital Evergreen Fund
Sector
Biotech
InvestorEMV Capital
Entry
2014
Hold
12yr
Polyphron
Vento Fund II
Sector
Biotech
InvestorVento
Entry
2025
Hold
1yr
ProTgen
Boehringer Ingelheim Venture Fund
Sector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
2024
Hold
2yr
Rampart Biosciences
HealthCap VIII
Sector
Biotech
InvestorHealthCap
Entry
2023
Hold
3yr
Recursion
Mubadala Capital Other Investments
Sector
Biotech
InvestorMubadala Capital
Entry
–
Recurv Pharma, Inc.
TVM Life Science Innovation
Sector
Biotech
InvestorTVM Capital Life Science
Entry
2023
Hold
3yr
Reservoir Neuroscience
KIZOO Evergreen (Balance Sheet)
Sector
Biotech
InvestorKIZOO Technology Capital
Entry
2024
Hold
2yr
Riva Therapeutics
Novo Holdings Venture Investments
Sector
Biotech
InvestorNovo Holdings
Entry
2022
Hold
4yr
Rubedo Life Sciences
Oscar & Paul Venture Capital Fund I
Sector
Biotech
InvestorOscar & Paul (Beiersdorf Venture Capital)
Entry
2024
Hold
2yr
Ruby Bio
Nucleus Capital II
Sector
Biotech
InvestorNucleus Capital
Entry
2025
Hold
1yr
Sorriso Pharmaceuticals
Lundbeckfonden BioCapital
Sector
Biotech
InvestorLundbeckfonden BioCapital
Entry
2021
Hold
5yr
Souffle Therapeutics
Leaps by Bayer
Sector
Biotech
InvestorLeaps by Bayer
Entry
2025
Hold
1yr
Strand Therapeutics
Kinnevik
Sector
Biotech
InvestorKinnevik
Entry
2025
Hold
1yr
Sudo Biosciences
Leaps by Bayer
Sector
Biotech
InvestorLeaps by Bayer
Entry
2024
Hold
2yr
T7 Therapeutics
TVM Life Science Innovation
Sector
Biotech
InvestorTVM Capital Life Science
Entry
2021
Hold
5yr
Tarveda Therapeutics
Novo Holdings Venture Investments
Sector
Biotech
InvestorNovo Holdings
Entry
2021
Hold
5yr
Terremoto Biosciences
Novo Holdings Venture Investments
Sector
Biotech
InvestorNovo Holdings
Entry
2023
Hold
3yr
Third Harmonic Bio
General Atlantic
Sector
Biotech
InvestorGeneral Atlantic
Entry
–
Vesigen Therapeutics
Leaps by Bayer
Sector
Biotech
InvestorLeaps by Bayer
Entry
2020
Hold
6yr
Vespina Life Sciences, Inc.
TVM Life Science Innovation
Sector
Biotech
InvestorTVM Capital Life Science
Entry
2021
Hold
5yr
Vincere Biosciences
Oscar & Paul Venture Capital Fund I
Sector
Biotech
InvestorOscar & Paul (Beiersdorf Venture Capital)
Entry
2025
Hold
1yr
Vir
Mubadala Capital Other Investments
Sector
Biotech
InvestorMubadala Capital
Entry
–